PN summer web series kicks off in July! Learn more


The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8, 2023, Webinar About Award Pre-Applications

CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) and the PRMRP will co-host an informative webinar on March 8, 2023, to help support researchers interested in submitting applications.

“With more than 30 million patients nationwide suffering from neuropathy, we are encouraged that our community’s advocacy efforts have led to funding for this debilitating condition,” said Lou Mazawey, FPN Board President. This funding success would not have been possible without our dedicated community who worked tirelessly with FPN to advocate for PN.

FY23 award mechanisms and pre-application deadlines:

  • Clinical Trial (no $ limit): April 12
  • Discovery ($200,000 maximum): March 29
  • Focused Program ($7.2 million maximum): April 12
  • Investigator-Initiated Research Award ($1.6 million maximum): April 19
  • Lifestyle and Behavioral Health Interventions ($3 million maximum): April 19
  • Technology/Therapeutic Development ($2 million): April 19

Most of the full applications are due April 26 and July 19, 2023, depending on the grant mechanism.

Peripheral neuropathy researchers are encouraged to submit pre-applications and register for the webinar hosted by FPN and the DoD PRMRP on March 8 via this link – webinar registration now closed.

Since its formation in 2007, FPN has worked tirelessly to advance peripheral neuropathy research to improve diagnosis, treatment, and management of this debilitating condition. In the first year for PN eligibility, the PRMRP received more than 1,000 applications for all eligible conditions. Forty-one focused on PN. Eight of those 41 projects were successful and resulted in more than $8 million in funding. In 2022, three of 28 applications were awarded funding totaling more than $4.6 million for PN grants.

For more information about the FY23 PRMRP, visit

FPN is a 501(c)(3) public non-profit committed to improving the lives of patients living with peripheral neuropathy. The organization helps accelerate the ability to diagnose, treat, prevent, and cure peripheral neuropathies through research funding and increased awareness of this condition.

The press release is available here.

The webinar recording is now available.

Leave a Comment